Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers

Gastroenterology

Volumn 117, Issue 2, 1999, Pages 350-358

  Sinicrope, F A ^a   Lemoine, M ^a   Xi, L ^a   Lynch, P M ^a   Cleary, K R ^a   Shen, Y ^a   Frazier, M L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADENOMATOUS POLYP; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032815687     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1999.0029900350     Document Type: Article

References (44)

1. E. Giovannucci K.M. Egan D.J. Hunter M.J. Stampfer G.A. Colditz W.C. Willett F.E. Speizer Aspirin and the risk of colorectal cancer in women N Engl J Med 333 1995 609 614
2. M.J. Thun M.M. Namboodiri C.W.J. Heath Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
3. Peleg II HT Maibach SH Brown CM. Wilcox Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer Arch Intern Med 154 1994 394 399
4. C.V. Rao A. Rivenson B. Simi E. Zang G. Kelloff V. Steele B.S. Reddy Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent Cancer Res 55 1995 1464 1472
5. R.F. Jacoby D.J. Marshall M.A. Newton K. Novakovic K. Tutsch C.E. Cole R.A. Lubet G.J. Kelloff A. Verma A.R. Moser W.F. Dove Chemoprevention of spontaneous intestinal adenomas in the ApcMin mouse model by the nonsteroidal anti-inflammatory drug piroxicam Cancer Res 56 1996 710 714
6. B.S. Reddy C.V. Rao A. Rivenson G. Kelloff Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 14 1993 1493 1497
7. C.W. Williams R.N. Dubois Prostaglandin endoperoxide synthase: who two isoforms? Am J Physiol 270 1996 G393 G400
8. C.E. Eberhart R.N. Dubois Eicosanoids and the gastrointestinal tract Gastroenterology 109 1995 285 301
9. H. Sheng J. Shao E.B. Hooton M. Tsujii R.N. Dubois R.D. Beauchamp Cyclooxygenase-2 induction and transforming growth factor β growth inhibition in rat intestinal epithelial cells Cell Growth Dif fer 8 1997 463 470
10. R.S. Gilbert S.T. Reddy S. Targar H.R. Herschman TGF-β1 augments expression of the TIS10/prostaglandin synthase-2 gene in intestinal epithelial cells Cell Mol Biol Res 40 1994 653 660
11. J. Xu D.S. Cissel S. Varghese D.L. Whipkey J.D. Blaha G.M. Graeber P.E. Keeting Cytokine regulation of adult human osteoblast-like cell prostaglandin biosynthesis J Cell Biochem 64 1997 618 631
12. M.G. Alexandrow H.L. Moses Transforming growth factor β and cell cycle regulation Cancer Res 55 1995 1452 1457
13. R. Parsons L.L. Myeroff B. Liu J.K.V. Willson S.D. Markowitz K.W. Kinzler B. Vogelstein Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer Cancer Res 55 1995 5548 5550
14. S. Markowitz J. Wang L. Myeroff R. Parson L.-Z. Sun J. Lutterbaugh R.S. Fan Zborowska K.W. Kinzler B. Vogelstein M. Brattain J.K.V. Willson Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability Science 268 1995 1336 1338
15. R.M. Dubois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
16. H. Sano Y. Kawahito R.L. Wilder A. Hashiramoto S. Mukai K. Asai S. Kimura H. Kato M. Kondo T. Hia Expression of cyclooxygen-ase-1 and -2 in human colorectal cancer Cancer Res 55 1995 3785 3789
17. R.N. Dubois A. Radhika B.S. Reddy A.J. Entingh Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 110 1996 1259 1262
18. C.S. Williams C. Luongo A. Radhika T. Zhang L.W. Lamps L.B. Nanney R.D. Beauchamp R.N. Dubois Elevated cyclooxygenase-2 levels in Min mouse adenomas Gastroenterology 111 1996 1134 1140
19. I. Nishisho Y. Nakamura Y. Miyoshi Y. Miki H. Ando A. Horii K. Koyama J. Utsunomiya S. Baba P. Hedge Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science 253 1991 665 669
20. J.L. Masferrer B.S. Zweifel P.T. Manning S.D. Hauser K.M. Leahy W.G. Smith P.C. Isakson K. Seibert Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic Proc Natl Acad Sci USA 91 1994 3228 3232
21. 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
22. B.S. Reddy C.V. Rao K. Siebert Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis Cancer Res 56 1996 4566 4569
23. H. Sheng J. Shao S.C. Kirkland P. Isakson R.J. Coffey J. Morrow R.D. Beauchamp R.N. Dubois Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 J Clin Invest 99 1997 2254 2259
24. F.M. Giardiello S.R. Hamilton A.J. Krush S. Piantadosi L.M. Hylind P. Celano S.V. Booker C.R. Robinson G.J. Offerhaus Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1993 1313 1316
25. G. Marra C.R. Boland Hereditary nonpolyposis colorectal cancer: the syndrome, the genes and historical perspectives J Natl Cancer Inst 87 1995 1114 1125
26. P Peltomaki HFA Vasen The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study Gastroenterology 113 1997 1146 1158
27. S.N. Thibodeau G. Bren D.J. Schaid Microsatellite instability in cancer of the proximal colon Science 260 1993 816 819
28. S. Wang R.F. Souza D. Kong J. Yin K.N. Smolinski T.-T. Zou T. Frank J. Young K.C. Flanders H. Sugimura J.M. Abraham S.J. Meltzer Deficient transforming growth factor-β1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptormutant tumors Cancer Res 57 1997 2543 2546
29. N. Rampino H. Yamamoto Y. Ionov Y. Li H. Sawai J.C. Reed M. Perucho Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype Science 275 1997 967 969
30. F.A. Sinicrope G. Roddey M. Lemoine S. Ruan L.C. Stephens M.L. Frazier Y. Shen W. Zhang Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers Clin Cancer Res 4 1998 1251 1261
31. M. Koi A. Umar D.P. Chauhan S.P. Cherian J.M. Carethers T.A. Kunkel C.R. Boland Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation Cancer Res 54 1994 4308 4312
32. S.C. Kirkland Dome formation by a human colonic adenocarcinoma cell line (HCA-7) Cancer Res 45 1985 3790 3795
33. C. Créminon A. Habib J. Maclouf P. Pradelles J. Grassi Y. Frobert Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays Biochim Biophys Acta 1254 1995 341 348
34. W. Kutchera D.A. Jones N. Matsunami J. Groden T.M. Mcintyre G.A. Zimmerman R.L. White S.M. Prescott Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect Proc Natl Acad Sci USA 93 1996 4816 4820
35. K.T. Wilson S. Fu K.S. Ramanujam S.J. Meltzer Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas Cancer Res 58 1998 2929 2934
36. M. Konishi R. Kikuchi-Yanoshita K. Tanaka M. Muraoka A. Onda Y. Okumura N. Kishi T. Iwama T. Mori M. Koike K. Ushio M. Chiba S. Nomizu F. Konishi J. Utsunomiya M. Miyaki Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer Gastroenterology 111 1996 307 317
37. M. Tsujii R.N. Dubois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
38. H. Sheng J. Shao J.D. Morrow R.D. Beauchamp R.N. Dubois Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells Cancer Res 58 1998 362 366
39. G.A. Piazza A.L. Rahm M. Krutzsch G. Sperl N.S. Paranka P.H. Gross K. Brendel R.W. Burt D.S. Alberts R. Pamukcu D.J. Ahnen Antineo-plastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis Cancer Res 55 1995 3110 3116
40. D.J. Elder D.E. Halton A. Hague C. Paraskeva Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression Clin Cancer Res 3 1997 1679 1683
41. E. Kipp S. Ghosh Inhibition of NF-kappaB by sodium salicylate and aspirin Science 265 1994 956 959
42. J. Rüschoff S. Wallinger W. Dietmahr T. Bocker G. Brockhoff F. Hoestadter R. Fishel Aspirin suppresses the mutator pheno-type associated with hereditary nonpolyposis colorectal cancer by genetic selection Proc Natl Acad Sci USA 95 1998 11301 11306
43. F.L. Lanza M.F. Rack D.A. Callison R.C. Hubbard S.S. Yu S. Talwalker G.S.A. Geis A pilot endoscopic study of the gastroduodenal effects of SC-58635, a novel COX-2 selective inhibitor (abstr) Gastroenterology 112 1997 A194
44. G. Deng A. Chen J. Hong H.S. Chae Y.S. Kim Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression Cancer Res 59 1999 2029 2033